Suicidal thoughts end Amgen's blockbuster aspirations for psoriasis drug

Nature biotechnology

Volumn 33, Issue 9, 2015, Pages 894-895

  Schmidt, Charlie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRODALUMAB; DERMATOLOGICAL AGENT; MONOCLONAL ANTIBODY;

CLINICAL TRIAL (TOPIC); DRUG INDUSTRY; EARLY TERMINATION OF CLINICAL TRIAL; HUMAN; ORGANIZATION AND MANAGEMENT; PSORIASIS; SUICIDAL IDEATION;

ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; DERMATOLOGIC AGENTS; DRUG INDUSTRY; EARLY TERMINATION OF CLINICAL TRIALS; HUMANS; PSORIASIS; SUICIDAL IDEATION;

EID: 84965094776     PISSN: None     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0915-894b     Document Type: Article

References (0)